Desq Long
Sign in

Company

Denali Therapeutics Inc.

DNLI · CIK 0001714899

SEC FORM 4
$36,867.66

Denali Therapeutics Inc. (DNLI)

Sale of 1,654 shares at $22.29 per share.

Reporting Person Chin Peter Scott · Officer Title Chief Medical Officer · Transaction Code S

Traded Sep 4, 2026 · Disclosed Sep 9, 2026

Source: SEC Form 4 · 0002124755-26-000007 · filed 2026-09-09 · View filing →

SEC FORM 4
$247,328.40

Denali Therapeutics Inc. (DNLI)

Sale of 10,824 shares at $22.85 per share.

Reporting Person Thornberry Nancy · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001797826-26-000006 · filed 2026-09-04 · View filing →

SEC FORM 4
$14,600.10

Denali Therapeutics Inc. (DNLI)

Sale of 615 shares at $23.74 per share.

Reporting Person Thornberry Nancy · Transaction Code S

Traded Sep 2, 2026 · Disclosed Sep 4, 2026

Source: SEC Form 4 · 0001797826-26-000006 · filed 2026-09-04 · View filing →

SEC FORM 4
$64,881.92

Denali Therapeutics Inc. (DNLI)

Sale of 2,768 shares at $23.44 per share.

Reporting Person Schuth Alexander O. · Officer Title COFO and Secretary · Transaction Code S

Traded Sep 1, 2026 · Disclosed Sep 3, 2026

Source: SEC Form 4 · 0001724311-26-000014 · filed 2026-09-03 · View filing →

SEC FORM 4
$71,624.99

Denali Therapeutics Inc. (DNLI)

Sale of 2,857 shares at $25.07 per share.

Reporting Person Schuth Alexander O. · Officer Title COFO and Secretary · Transaction Code S

Traded Aug 11, 2026 · Disclosed Aug 13, 2026

Source: SEC Form 4 · 0001724311-26-000013 · filed 2026-08-13 · View filing →